Close Menu

NEW YORK — PredictImmune said on Tuesday that it has signed an agreement for promotion and distribution of its PredictSure IBD test in the UK, Ireland, the Middle East, and the Balkans with Cambridge Clinical Laboratories (CCL).

PredictSure IBD is a PCR-based test is designed to analyze the expression of 17 genes in whole blood in order to differentiate mild and aggressive forms of Crohn's disease and ulcerative colitis and to guide treatment options.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
26

As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.